DE3940067A1 - Steroidogenese induzierendes protein (sip) - Google Patents

Steroidogenese induzierendes protein (sip)

Info

Publication number
DE3940067A1
DE3940067A1 DE3940067A DE3940067A DE3940067A1 DE 3940067 A1 DE3940067 A1 DE 3940067A1 DE 3940067 A DE3940067 A DE 3940067A DE 3940067 A DE3940067 A DE 3940067A DE 3940067 A1 DE3940067 A1 DE 3940067A1
Authority
DE
Germany
Prior art keywords
hormone
cells
sip
medicament according
chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE3940067A
Other languages
German (de)
English (en)
Other versions
DE3940067C2 (enExample
Inventor
Erfinder Wird Nachtraeglich Benannt Der
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Khan Shafig Ahmed Drmedsci Toronto Ontario
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority to DE3940067A priority Critical patent/DE3940067A1/de
Priority to US07/709,073 priority patent/US5484767A/en
Publication of DE3940067A1 publication Critical patent/DE3940067A1/de
Application granted granted Critical
Publication of DE3940067C2 publication Critical patent/DE3940067C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3940067A 1989-12-04 1989-12-04 Steroidogenese induzierendes protein (sip) Granted DE3940067A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE3940067A DE3940067A1 (de) 1989-12-04 1989-12-04 Steroidogenese induzierendes protein (sip)
US07/709,073 US5484767A (en) 1989-12-04 1991-05-30 Substantially pure steroidogenesis inducing protein and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3940067A DE3940067A1 (de) 1989-12-04 1989-12-04 Steroidogenese induzierendes protein (sip)
US07/709,073 US5484767A (en) 1989-12-04 1991-05-30 Substantially pure steroidogenesis inducing protein and uses thereof

Publications (2)

Publication Number Publication Date
DE3940067A1 true DE3940067A1 (de) 1991-06-06
DE3940067C2 DE3940067C2 (enExample) 1992-11-12

Family

ID=25887652

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3940067A Granted DE3940067A1 (de) 1989-12-04 1989-12-04 Steroidogenese induzierendes protein (sip)

Country Status (2)

Country Link
US (1) US5484767A (enExample)
DE (1) DE3940067A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519889A3 (en) * 1991-06-18 1993-07-21 The Population Council Center For Biomedical Research Leydig cell stimulator

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) * 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
US4945055A (en) * 1986-05-15 1990-07-31 Board Of Regents, University Of Texas System Human chorionic gonadotropin releasing factor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Acta Endocrinologica 118, S. 283-293, 1988 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519889A3 (en) * 1991-06-18 1993-07-21 The Population Council Center For Biomedical Research Leydig cell stimulator

Also Published As

Publication number Publication date
DE3940067C2 (enExample) 1992-11-12
US5484767A (en) 1996-01-16

Similar Documents

Publication Publication Date Title
DE69736976T2 (de) Mit Alzheimer Krankheit verknüpften Verfahren zur Diagnose, zur Herstellung von Medikamenten und zum Screenen von Substanzen sowie aus Beta-Amyloid abgeleiteten Peptiden
EP0167575B1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung
AU631108B2 (en) Method to prepare a composition for treatment of amyotrophic lateral sclerosis
Woolley et al. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat
DE3587603T2 (de) Aus follikularer eierstockflüssigkeit isoliertes inhibin.
DE69227347T2 (de) Auf rezeptorgrundlage arbeitende screening-verfahren für amylin-agonisten und- antagonisten
DE69232008T2 (de) Verwendung von insulinähnlichen Wachstumsfaktoren und Analogen zur BEHANDLUNG VON ERKRANKUNGEN DER SEHNERVEN
EP0021152B1 (de) Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung
EP0149468A2 (de) Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke
DE3935738A1 (de) Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
DE3751316T2 (de) Materialzusammensetzung, welche ein Polypeptid aus Pankreas-Insel-Amyloid und/oder Antikörpern gegen dieses Polypeptid enthält, und Anwendung dieser Zusammensetzung.
DE60034117T2 (de) Verfahren zur herstelllung von gonadotropin-zusammensetzungen
DE69100376T2 (de) Verfahren zur hemmung der follikelreifung.
DE69026986T2 (de) Amylin zur Behandlung von Knochenleiden
DE69906064T2 (de) Glycoproteine mit lipidmobilisierenden eigenschaften und deren therapeutische verwendungen
DE4132587C1 (enExample)
EP0107045A1 (de) Verfahren zur Gewinnung von Relaxin aus Milch
DE69720693T2 (de) Fsh und lh trennungs- und reinigungsverfahren
DE60124915T2 (de) Synthetische peptide gegen neurologische krankheiten
DE3787185T2 (de) Methode zur Erhöhung des Wachstums des Brustzellgewebes.
DE3940067C2 (enExample)
Greep Separation of a thyrotropic from the gonadotropic substances of the pituitary
DE69029040T2 (de) Megakaryocytopoietischer faktor
Sbaschnig‐Agler et al. Ganglioside changes in the regenerating goldfish optic system: Comparison with glycoproteins and phospholipids
DE60036638T2 (de) Verwendung von colostrinin, dessen peptidbestandteile und deren analoga zur förderung der neuronalen zelldifferenzierung

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8181 Inventor (new situation)

Free format text: NIESCHLAG, EBERHARD, PROF. DR., 4400 MUENSTER, DE KHAN, SHAFIG AHMED, DR.MED., TORONTO, ONTARIO, CA

8127 New person/name/address of the applicant

Owner name: KHAN, SHAFIG AHMED, DR.MED.SCI., TORONTO, ONTARIO,

8128 New person/name/address of the agent

Representative=s name: WEICKMANN, H., DIPL.-ING. FINCKE, K., DIPL.-PHYS.

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee